Clinical trial
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
NCT00371995 · Banaras Hindu University, Other · Completed
Key facts
| NCT number | NCT00371995 |
|---|---|
| Title | Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar |
| Official title | The Efficacy and Safety of a Short Course of Miltefosine and Liposomal Amphotericin B for Visceral Leishmaniasis in India |
| Lead sponsor | Banaras Hindu University, Other |
| Collaborators | Rajendra Memorial Research Institute of Medical Sciences |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Visceral Leishmaniasis |
| Intervention type | Drug |
| Interventions | Liposomal amphotericin B and Miltefosine |
| Enrollment | 150 |
| Start date | Oct 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | Sep 6, 2006 |
| Last update posted | Jun 22, 2011 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: